Please Wait
Applying Filters...
menu
    • menu
    DMF filings rise 4.5% in Q3 2025; China holds lead, India records 20% growth in submissions

    Data Compilation
    #PharmaFlow

    Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

    Stock Recap
    #PipelineProspector

    Menu

    Cefmenoxime HCl

    ACTIVE PHARMA INGREDIENTS

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Holder DMF No. Subject Submission Date Status Type GDUFA DMF Review GDUFA Review Date GDUFA Payment Date
    31/10/2025 Takeda Pharmaceutical
    Japan
    		 TAKEDA CHEMICAL INDUSTRIES LTD 4616 MANUF OF CEFMENOXIME HCL IN THE HIKARI PLANT 1982-07-12 Inactive II N/A
    31/10/2025 Takeda Pharmaceutical
    Japan
    		 TAKEDA CHEMICAL INDUSTRIES LTD 4468 PHARMACEUTICAL PROCESSING OF CEFMENOXINE HCL FOR INJECT -HIKARI PLANT 1982-01-25 Inactive II N/A